Healthcare Veteran Stephen l. Newman, M.M., Joins Zavante Therapeutics’ Board of Directors by Carolyn Helms | Sep 6, 2016 | Portfolio News
Aimmune Therapeutics to Host Conference Call on Potential Positive Implications for AR101 Development From Independent Academic Study Showing Oral Immunotherapy Induces Sustained Unresponsiveness in Young Peanut-Allergic Children by Carolyn Helms | Aug 18, 2016 | Portfolio News
Collegium Announces Publication of Data on Alternative Modes of Administration of Xtampza ER by Carolyn Helms | Aug 16, 2016 | Portfolio News
Aimmune Therapeutics Announces Second Quarter 2016 Financial Results by Carolyn Helms | Aug 10, 2016 | Portfolio News
